Healthcare Due Diligence Risks Most Buyers Miss

Healthcare mergers and acquisitions fail for reasons that don’t appear on the financial statements. Payer mix looks strong, patient volume is growing, real estate is clean. Then, three months post-close, a provider contract issue surfaces that restructures the revenue projection entirely. The complexity of these transactions means buyers who rely on standard financial and legal review consistently miss the operational and regulatory risks that drive post-close losses.

The Reimbursement Model Blind Spot

Checking payer mix and reimbursement rates is necessary but not sufficient. What due diligence teams less often examine is the trajectory of those reimbursement models. A practice heavily dependent on fee-for-service revenue might look strong on current financials, but if major payers are moving toward value-based arrangements, those margins can erode quickly after close.

Understanding the target’s infrastructure matters as much as its current contracts. Pending payer renewals, alternative payment model participation and the practice’s data analytics capabilities all determine whether a post-acquisition reimbursement transition is feasible. Practices that lack the care coordination systems or quality reporting infrastructure to support value-based arrangements can’t make that shift quickly. That’s a multi-year, capital-intensive problem that needs to be priced into the deal, not discovered after close.

Provider Contracts and Retention Issues

Healthcare acquisitions differ from most asset purchases because the most valuable assets are people. Provider employment agreements require thorough review: non-compete clauses, compensation structures, call coverage requirements and partnership track commitments all affect deal value. But so do the informal dynamics that don’t appear in any document.

Who actually controls patient relationships? Are referral patterns built on organizational infrastructure or personal ones that follow the physician? What happens if the founding physician decides retirement looks more attractive than working for new owners? These questions need direct answers, not assumptions.

Physician burnout remains a material retention risk worth quantifying during diligence. Per the AMA’s 2025 Organizational Biopsy, 41.9% of physicians reported at least one burnout symptom in 2025, with intent to leave tracking as a separate performance indicator. Understanding where the target’s providers sit on those measures, and what’s driving their current engagement, directly affects revenue durability post-close.

Compliance Risks That Don’t Show Up in Audits

Verifying Stark Law and Anti-Kickback compliance, reviewing billing practices and checking the OIG exclusions database for any listed providers are standard steps. They’re also insufficient on their own. The compliance risks with the most post-close impact often live in operational practices that haven’t triggered enforcement action yet.

Incident reporting processes, breach notification history, and telehealth licensing compliance across states all warrant careful examination. Private equity-backed healthcare platforms face heightened scrutiny regarding balance billing practices and network adequacy claims. A clean audit history doesn’t mean current operational practices align with present enforcement priorities. Acquiring that misalignment is buying future liability.

Technology and Data Infrastructure

Electronic health record systems typically get reviewed for functionality during diligence. The questions that matter more are often skipped. Who owns the data? What do the software agreements actually allow in terms of portability and integration? Can systems be consolidated across a platform, or does the acquisition lock the buyer into running multiple incompatible EHR environments indefinitely?

Data migration in healthcare is subject to strict regulatory requirements around access, privacy and retention. Integration projects that seemed straightforward at close can stall for years when data ownership and portability weren’t addressed during diligence.

Cybersecurity posture also warrants specific assessment. Healthcare remains a primary ransomware target, and a breach during post-close integration can simultaneously destroy deal value and generate regulatory liability.

Build Healthcare Due Diligence Around What Matters

Healthcare transactions require specialized expertise that goes beyond standard financial and legal review. The regulatory environment, reimbursement complexity and human capital dynamics create risks that generalist advisors consistently underweight. A due diligence process built around these dimensions surfaces the risks that affect deal value before they become post-close problems.

James Moore’s healthcare team works alongside buyers to identify and quantify operational and regulatory risks in healthcare acquisitions. Contact us when you’re evaluating a transaction and want due diligence that catches what matters.

All content provided in this article is for informational purposes only. Matters discussed in this article are subject to change. For up-to-date information on this subject please contact a James Moore professional. James Moore will not be held responsible for any claim, loss, damage or inconvenience caused as a result of any information within these pages or any information accessed through this site.